Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery

Clinical trial NCT02234180 · TERMINATED

Trial details

NCT number: NCT02234180
Sponsor: Academic and Community Cancer Research United
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Gastroesophageal Junction Stage IIB Esophageal Adenocarcinoma Stage IIIA Esophageal Adenocarcinoma Stage IIIB Esophageal Adenocarcinoma Stage IIIC Esophageal Adenocarcinoma

Start date: 2014-09-01
Primary completion: 2016-06-08
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.